HAIR Restoration Robotics Inc

Keith Sullivan Joins Board of Directors of Restoration Robotics®

Keith Sullivan Joins Board of Directors of Restoration Robotics®

Former Chief Commercial Officer and President of ZELTIQ® Aesthetics Joins Restoration Robotics Board of Directors

SAN JOSE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ:HAIR), a global leader in robotic hair restoration, today announced the effectiveness of the appointment of Keith Sullivan to the Company’s board of directors. Mr. Sullivan’s appointment allows the Company to leverage his deep aesthetic industry and commercial experience to enhance efforts to drive the adoption of its ARTAS® Robotic Hair Restoration System.

Ryan Rhodes, President and Chief Executive Officer of Restoration Robotics, said, “I am excited to have Keith join our Board. We believe that his 30 years in sales leadership and extensive experience operating and commercializing leading aesthetic products will be instrumental to the growth of our business, as we look to expand the efficiency and effectiveness of our commercial infrastructure ahead of our implantation functionality launch. We have no doubt that Keith’s addition will further advance both our near and long-term strategic initiatives and our objective to become the leader in hair restoration.”

Mr. Sullivan commented, “Restoration Robotics has a unique opportunity to penetrate and expand the large and growing hair restoration market by bringing the ARTAS system to the forefront of treatment options for hair restoration. I look forward to working with management to best position the Company for commercial success.”

Most recently, Mr. Sullivan was Chief Commercial Officer and President, North America of ZELTIQ Aesthetics, Inc., and currently serves as a member of the Board of Directors and Interim General Manager of miraDry® at Sientra®, Inc. At ZELTIQ, Mr. Sullivan led the restructuring of the global commercial organization, accomplishing a near 50% 4-year CAGR and was an integral part in the Company’s acquisition by Allergan. Mr. Sullivan previously held positions with Medicis Pharmaceuticals, Reliant Technologies, Medtronic, Vision Quest Laser Center and Coherent Medical.

About Restoration Robotics

Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS™ Robotic Hair Restoration System. We believe the ARTAS System is the first and only physician-assisted system to dissect, and assist in the harvesting of, follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.

Media Contact

Lisa Markle

Director of Marketing

Restoration Robotics, Inc.



Investor Contact

The Ruth Group

Lee Roth & Brian Johnston



646-536-7000

EN
02/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Restoration Robotics Inc

 PRESS RELEASE

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial ...

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial Results; Provides Preliminary First Quarter of 2020 Revenue Results and Updates Fiscal Year 2020 Revenue Guidance TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the three months ending March 31, 2020. The Company notes that the financial results provided for the three months and twelv...

 PRESS RELEASE

Venus Concept Inc. Announces $22.25 Million Equity Financing

Venus Concept Inc. Announces $22.25 Million Equity Financing TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible preferred stock and warrants to purchase common stock in a private placement to a group of investors, including EW Healthcare Partners, HealthQuest Capital and SEDCO Capital. The private placement is expected to result in gross proceeds to the Compa...

 PRESS RELEASE

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial...

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 30, 2020 TORONTO, March 10, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30. Management will host a conference call at 5:00 p.m. Eastern Time on March 30 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may di...

 PRESS RELEASE

Venus Concept Expands Executive Team

Venus Concept Expands Executive Team Chad A. Zaring, Appointed Chief Commercial Officer TORONTO, March 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A. Zaring to the newly-created role of Chief Commercial Officer (“CCO”), effective February 10, 2020. Mr. Zaring has extensive experience in building and executing commercial strategies and driving sales for leading surgical robotics companies in his career. “We ar...

 PRESS RELEASE

Venus Concept Inc. Announces New Regulatory Clearances

Venus Concept Inc. Announces New Regulatory Clearances CE Mark Approval for Venus Bliss™️ for Non-Invasive Lipolysis of Abdomen & Flanks, Skin Tightening, Circumferential Reduction and Cellulite ReductionHealth Canada License to Market NeoGraft 2.0 for hair restoration TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE Mark approval to market Venus Bliss for non-invasive lipolysis of the abdomen and flanks, skin tightening, circumferential re...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch